Abstract
Historically, much controversy has existed regarding the association of inherited thrombophilias with adverse pregnancy outcomes. The current guidelines do not recommend screening unless a personal history of venous thromboembolism is present, but the authors' survey of physician screening patterns has suggested that up to 40% of physicians may screen contrary to the current guidelines. This article summarizes the existing evidence for each inherited thrombophilia and reviews the current guidelines.
Keywords:
Inherited thrombophilias; Intrauterine growth restriction; OB/GYN; Placental abruption; Preeclampsia; Pregnancy; Recurrent pregnancy loss.
Copyright © 2014 Elsevier Inc. All rights reserved.
MeSH terms
-
Abortion, Habitual / blood
-
Abortion, Habitual / etiology
-
Abortion, Habitual / genetics*
-
Antibodies, Anticardiolipin / blood
-
Factor V / genetics
-
Female
-
Fetal Growth Retardation
-
Genetic Testing*
-
Guideline Adherence
-
Humans
-
Lupus Coagulation Inhibitor / blood
-
Methylenetetrahydrofolate Reductase (NADPH2) / genetics
-
Mutation
-
Patient Selection
-
Practice Guidelines as Topic
-
Pre-Eclampsia / blood
-
Pre-Eclampsia / etiology
-
Pre-Eclampsia / genetics*
-
Pregnancy
-
Pregnancy Complications, Hematologic / blood
-
Pregnancy Complications, Hematologic / genetics*
-
Pregnancy Outcome
-
Protein C Deficiency / complications
-
Protein S Deficiency / complications
-
Prothrombin / genetics
-
Risk Factors
-
Thrombophilia / blood
-
Thrombophilia / complications
-
Thrombophilia / genetics*
-
Venous Thromboembolism / blood
-
Venous Thromboembolism / etiology
-
Venous Thromboembolism / genetics*
Substances
-
Antibodies, Anticardiolipin
-
Lupus Coagulation Inhibitor
-
factor V Leiden
-
Factor V
-
Prothrombin
-
MTHFR protein, human
-
Methylenetetrahydrofolate Reductase (NADPH2)